doi:10.1186/s13063-018-2636-1Jo Sang-HoPark Sung-JiKim Eung JuKim Soo-JoongCho Hyun-JaeSong Jong-MinShin JinhoPark Jin JooShin Joon-HanHan Kyoo-RokBioMed CentralTrials
Calcium channel blockers are among the first-line drugs for treatment of hypertension (HTN). S-amlodipine (S-AM), an S-enantiomer of amlodipine, is available in India and in other countries like Chin...
Changes in mean sitting diastolic blood pressure also were not significant (–14.71 [6.94] vs –10.88 [5.81] mm Hg; P = 0.091). One patient in each group had facial edema, and another patient in the amlodipine besylate group had facial flushing. Overall, there was no significant difference...
We investigate the safety and efficacy of telmisartan plus S-amlodipine single-pill combination in a real-world population. A total of 44,715 patients who
【摘要】本文意图比较左旋氨氯地平与氨氯地平两者的成本效果差异。采用两个多中心的头对头临床 随机对照试验,结合药品的治疗费用进行回顾性的成本效果分析。结果:治疗4-8周后,左旋氨氯地平组 110例治疗有效率为84.91%。氨氯地平组107例治疗有效率为77.45%,两组间没有统计学的显著差异。氨 ...
Amlodipine vs. Nifedipine — What's the Difference? By Tayyaba Rehman— Updated on October 30, 2023 Amlodipine and Nifedipine are calcium channel blockers used to treat hypertension, but they differ in their duration of action and specific uses....
The incidence of fatal hemorrhagic stroke was similar across treatment groups (17 vs. 18 for the atorvastatin and placebo groups, respectively). The incidence of non-fatal hemorrhagic stroke was significantly higher in the atorvastatin group (38, 1.6%) as compared to the placebo group (16, 0.7...
Background: Recent hypertension trials have demonstrated the importance of achieving goal blood pressures to reduce the risk of target organ damage. In patients with moderate to severe hypertension, the use of high-dose monotherapy and/or combinations of
<div p-id="A-0001" num="0001">The present invention relates to the stable solid orally administrable pharmaceutical formulation of Amlodipine Maleate. The invention also describes the process of produ
We plan to compare the efficacy and safety of S-amlodipine (CCB) plus chlorthalidone versus S-amlodipine plus telmisartan (ARB) combinations among hypertension patients unresponsive to amlodipine monotherapy. This study is a prospective, randomized, double-blind, multicenter, parallel, non-inferiority ...